| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae Proteins | 27 | 2024 | 299 | 5.790 |
Why?
|
| Meiosis | 22 | 2024 | 84 | 5.650 |
Why?
|
| Rad51 Recombinase | 28 | 2019 | 81 | 5.420 |
Why?
|
| Cell Cycle Proteins | 21 | 2024 | 409 | 5.000 |
Why?
|
| DNA-Binding Proteins | 32 | 2019 | 1234 | 4.950 |
Why?
|
| Saccharomyces cerevisiae | 30 | 2024 | 460 | 4.590 |
Why?
|
| Recombination, Genetic | 18 | 2024 | 419 | 2.460 |
Why?
|
| DNA, Single-Stranded | 13 | 2019 | 95 | 1.970 |
Why?
|
| Rec A Recombinases | 7 | 2021 | 14 | 1.960 |
Why?
|
| Homologous Recombination | 12 | 2024 | 57 | 1.860 |
Why?
|
| DNA Breaks, Double-Stranded | 7 | 2024 | 72 | 1.810 |
Why?
|
| Heart Transplantation | 14 | 2015 | 811 | 1.640 |
Why?
|
| Graft Rejection | 13 | 2015 | 1120 | 1.630 |
Why?
|
| DNA Repair | 19 | 2015 | 361 | 1.440 |
Why?
|
| DNA Helicases | 8 | 2018 | 89 | 1.380 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2019 | 65 | 1.340 |
Why?
|
| DNA | 8 | 2021 | 1265 | 1.330 |
Why?
|
| Crossing Over, Genetic | 8 | 2019 | 34 | 1.210 |
Why?
|
| Recombinases | 5 | 2019 | 22 | 1.130 |
Why?
|
| Adenosine Triphosphatases | 8 | 2021 | 141 | 1.130 |
Why?
|
| CD40 Ligand | 7 | 2013 | 77 | 1.030 |
Why?
|
| CD40 Antigens | 5 | 2013 | 43 | 1.010 |
Why?
|
| Recombinational DNA Repair | 2 | 2018 | 10 | 0.930 |
Why?
|
| Exodeoxyribonucleases | 2 | 2024 | 16 | 0.910 |
Why?
|
| Replication Protein A | 7 | 2019 | 16 | 0.900 |
Why?
|
| DNA Replication | 4 | 2019 | 168 | 0.870 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2024 | 38 | 0.860 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2024 | 35 | 0.850 |
Why?
|
| Graft Survival | 11 | 2015 | 937 | 0.820 |
Why?
|
| Adenosine Triphosphate | 3 | 2021 | 319 | 0.780 |
Why?
|
| DNA Topoisomerases | 4 | 2018 | 4 | 0.740 |
Why?
|
| Transforming Growth Factor beta | 3 | 2009 | 347 | 0.710 |
Why?
|
| DNA Damage | 12 | 2019 | 389 | 0.620 |
Why?
|
| Fungal Proteins | 6 | 2004 | 145 | 0.610 |
Why?
|
| Chromosomes, Fungal | 5 | 2019 | 15 | 0.600 |
Why?
|
| Transplantation, Homologous | 14 | 2015 | 1014 | 0.590 |
Why?
|
| Nuclear Proteins | 6 | 2019 | 740 | 0.580 |
Why?
|
| DNA, Fungal | 7 | 2019 | 60 | 0.570 |
Why?
|
| Interleukin-17 | 2 | 2009 | 109 | 0.560 |
Why?
|
| Mice, Inbred BALB C | 14 | 2015 | 1101 | 0.520 |
Why?
|
| BRCA1 Protein | 4 | 2007 | 214 | 0.520 |
Why?
|
| Multiprotein Complexes | 3 | 2015 | 106 | 0.500 |
Why?
|
| Immune System | 1 | 2017 | 101 | 0.480 |
Why?
|
| Immunologic Techniques | 1 | 2015 | 25 | 0.460 |
Why?
|
| Models, Biological | 5 | 2019 | 1768 | 0.460 |
Why?
|
| Chromosome Pairing | 3 | 2015 | 4 | 0.440 |
Why?
|
| Antibodies, Monoclonal | 5 | 2013 | 1395 | 0.410 |
Why?
|
| Cisplatin | 6 | 2011 | 568 | 0.400 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2013 | 4 | 0.400 |
Why?
|
| Receptors, OX40 | 2 | 2011 | 4 | 0.380 |
Why?
|
| Mice | 20 | 2017 | 12269 | 0.370 |
Why?
|
| T-Lymphocytes | 4 | 2015 | 1275 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 14 | 2015 | 3435 | 0.370 |
Why?
|
| Genes, BRCA1 | 3 | 2007 | 191 | 0.370 |
Why?
|
| Animals | 31 | 2017 | 28155 | 0.370 |
Why?
|
| Nucleic Acid Conformation | 3 | 2019 | 342 | 0.350 |
Why?
|
| Microbiota | 1 | 2017 | 425 | 0.350 |
Why?
|
| DNA, Cruciform | 3 | 2007 | 5 | 0.340 |
Why?
|
| Calcium | 2 | 2014 | 1176 | 0.340 |
Why?
|
| Transplantation Tolerance | 4 | 2011 | 143 | 0.340 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 337 | 0.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2019 | 392 | 0.330 |
Why?
|
| DNA Repair Enzymes | 7 | 2015 | 61 | 0.330 |
Why?
|
| Synaptonemal Complex | 3 | 2015 | 4 | 0.330 |
Why?
|
| Cell Nucleus | 5 | 2010 | 603 | 0.320 |
Why?
|
| Interleukin-6 | 1 | 2011 | 276 | 0.320 |
Why?
|
| Hydrolysis | 2 | 2021 | 141 | 0.310 |
Why?
|
| Chickens | 6 | 2011 | 206 | 0.300 |
Why?
|
| Proteoglycans | 1 | 2009 | 122 | 0.300 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2009 | 132 | 0.290 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 436 | 0.290 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 797 | 0.290 |
Why?
|
| CD8 Antigens | 1 | 2008 | 82 | 0.280 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 481 | 0.280 |
Why?
|
| Mutation | 10 | 2019 | 4272 | 0.280 |
Why?
|
| Interferon-gamma | 7 | 2015 | 460 | 0.280 |
Why?
|
| Breast Neoplasms | 3 | 2008 | 3110 | 0.270 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 149 | 0.270 |
Why?
|
| Th1 Cells | 2 | 2009 | 167 | 0.260 |
Why?
|
| T-Box Domain Proteins | 1 | 2008 | 127 | 0.260 |
Why?
|
| Genes, BRCA2 | 1 | 2008 | 162 | 0.260 |
Why?
|
| Signal Transduction | 5 | 2015 | 3502 | 0.250 |
Why?
|
| Mitosis | 2 | 2010 | 150 | 0.250 |
Why?
|
| Saccharomycetales | 1 | 2006 | 15 | 0.240 |
Why?
|
| Schizosaccharomyces | 1 | 2006 | 56 | 0.240 |
Why?
|
| Transfection | 3 | 2010 | 880 | 0.240 |
Why?
|
| Chromatin | 3 | 2014 | 440 | 0.230 |
Why?
|
| Mice, Knockout | 8 | 2013 | 2121 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 887 | 0.230 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 154 | 0.220 |
Why?
|
| Fibrosis | 3 | 2012 | 230 | 0.220 |
Why?
|
| Models, Genetic | 5 | 2019 | 970 | 0.220 |
Why?
|
| Genes, Fungal | 2 | 2006 | 62 | 0.210 |
Why?
|
| Caffeine | 2 | 2015 | 85 | 0.210 |
Why?
|
| Protein Binding | 4 | 2018 | 1534 | 0.210 |
Why?
|
| Gene Conversion | 3 | 2015 | 23 | 0.200 |
Why?
|
| Biochemistry | 1 | 2004 | 29 | 0.200 |
Why?
|
| Cell Proliferation | 6 | 2015 | 1741 | 0.190 |
Why?
|
| Neoplasms | 2 | 2015 | 3169 | 0.190 |
Why?
|
| Models, Molecular | 3 | 2014 | 1353 | 0.190 |
Why?
|
| Cross-Linking Reagents | 4 | 2012 | 89 | 0.190 |
Why?
|
| Reoperation | 1 | 2005 | 702 | 0.190 |
Why?
|
| Protein Transport | 1 | 2004 | 438 | 0.180 |
Why?
|
| Nucleic Acid Renaturation | 1 | 2001 | 5 | 0.180 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 83 | 0.180 |
Why?
|
| DNA, Superhelical | 1 | 2001 | 15 | 0.180 |
Why?
|
| Recombinant Proteins | 3 | 2018 | 988 | 0.170 |
Why?
|
| Neoplasm Proteins | 2 | 2001 | 537 | 0.170 |
Why?
|
| Personnel Selection | 1 | 2021 | 62 | 0.160 |
Why?
|
| Peptides | 1 | 2004 | 656 | 0.160 |
Why?
|
| Benzamides | 2 | 2014 | 246 | 0.160 |
Why?
|
| Humans | 21 | 2021 | 93515 | 0.160 |
Why?
|
| X-Rays | 1 | 2000 | 138 | 0.160 |
Why?
|
| Th2 Cells | 2 | 2013 | 149 | 0.160 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2000 | 58 | 0.160 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 15 | 0.160 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 2012 | 0.160 |
Why?
|
| BRCA2 Protein | 3 | 2011 | 173 | 0.160 |
Why?
|
| Dendritic Cells | 1 | 2004 | 536 | 0.150 |
Why?
|
| Suppression, Genetic | 1 | 1999 | 30 | 0.150 |
Why?
|
| Protein Stability | 1 | 2019 | 103 | 0.150 |
Why?
|
| Sulfonamides | 2 | 2014 | 331 | 0.150 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 2910 | 0.150 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2755 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 331 | 0.140 |
Why?
|
| Chromosome Segregation | 2 | 2019 | 35 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2012 | 960 | 0.140 |
Why?
|
| Escherichia coli | 2 | 2018 | 563 | 0.140 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2018 | 31 | 0.140 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 2 | 2007 | 3 | 0.140 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 120 | 0.130 |
Why?
|
| Transcription Factors | 3 | 2010 | 1691 | 0.130 |
Why?
|
| Base Pairing | 2 | 2008 | 55 | 0.130 |
Why?
|
| Base Sequence | 2 | 2014 | 2220 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 307 | 0.130 |
Why?
|
| Germ-Free Life | 1 | 2017 | 83 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 257 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2002 | 761 | 0.120 |
Why?
|
| Sister Chromatid Exchange | 1 | 2015 | 13 | 0.120 |
Why?
|
| Formaldehyde | 2 | 2007 | 51 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 660 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2009 | 730 | 0.120 |
Why?
|
| Immunity | 2 | 2015 | 153 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2004 | 2303 | 0.110 |
Why?
|
| Endonucleases | 1 | 2015 | 21 | 0.110 |
Why?
|
| Mutagens | 1 | 2015 | 29 | 0.110 |
Why?
|
| Epistasis, Genetic | 3 | 2011 | 90 | 0.110 |
Why?
|
| Female | 10 | 2012 | 48702 | 0.110 |
Why?
|
| Time Factors | 5 | 2015 | 5410 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 266 | 0.100 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 701 | 0.100 |
Why?
|
| Chromatids | 1 | 2013 | 7 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 192 | 0.100 |
Why?
|
| S Phase | 2 | 2007 | 64 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 162 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 555 | 0.100 |
Why?
|
| Exons | 1 | 2014 | 450 | 0.090 |
Why?
|
| Flow Cytometry | 2 | 2015 | 712 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2012 | 98 | 0.090 |
Why?
|
| Morpholines | 1 | 2012 | 61 | 0.090 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 179 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 319 | 0.090 |
Why?
|
| Fibronectins | 1 | 2012 | 100 | 0.090 |
Why?
|
| Homeostasis | 1 | 2013 | 460 | 0.090 |
Why?
|
| Cell Survival | 4 | 2014 | 1004 | 0.090 |
Why?
|
| Pyrroles | 1 | 2012 | 165 | 0.090 |
Why?
|
| Ku Autoantigen | 2 | 2007 | 15 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 248 | 0.080 |
Why?
|
| Antigens, Nuclear | 2 | 2007 | 28 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 296 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 646 | 0.080 |
Why?
|
| Interleukin-2 | 3 | 2011 | 244 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2011 | 321 | 0.080 |
Why?
|
| Decorin | 1 | 2009 | 6 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 590 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 160 | 0.070 |
Why?
|
| Spleen | 2 | 2012 | 374 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 174 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 641 | 0.070 |
Why?
|
| Transplantation, Heterotopic | 1 | 2009 | 47 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2009 | 15 | 0.070 |
Why?
|
| Granulocytes | 1 | 2009 | 35 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2007 | 515 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2012 | 120 | 0.070 |
Why?
|
| Myocardium | 1 | 2012 | 570 | 0.070 |
Why?
|
| DNA, Circular | 1 | 2008 | 11 | 0.070 |
Why?
|
| Sciatic Nerve | 1 | 2008 | 37 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1264 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 137 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2008 | 69 | 0.070 |
Why?
|
| Disinfectants | 1 | 2007 | 8 | 0.070 |
Why?
|
| Cytidine Deaminase | 1 | 2007 | 25 | 0.070 |
Why?
|
| G2 Phase | 1 | 2007 | 31 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 83 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2008 | 88 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2850 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2008 | 636 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 2 | 2015 | 15 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 87 | 0.070 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2006 | 3 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 175 | 0.060 |
Why?
|
| Peroneal Nerve | 1 | 2006 | 9 | 0.060 |
Why?
|
| RNA, Double-Stranded | 1 | 2006 | 22 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 216 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1621 | 0.060 |
Why?
|
| RNA, Fungal | 1 | 2006 | 43 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2005 | 46 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2008 | 375 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1799 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 86 | 0.060 |
Why?
|
| Transgenes | 1 | 2005 | 171 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2005 | 134 | 0.060 |
Why?
|
| Cell Movement | 1 | 2009 | 809 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2006 | 176 | 0.050 |
Why?
|
| Bacteriophage M13 | 1 | 2004 | 8 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2005 | 340 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2006 | 299 | 0.050 |
Why?
|
| Peptide Library | 1 | 2004 | 84 | 0.050 |
Why?
|
| Respirovirus Infections | 1 | 2003 | 7 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2015 | 517 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 863 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 280 | 0.050 |
Why?
|
| Chromosomes | 1 | 2004 | 91 | 0.050 |
Why?
|
| Receptors, Interleukin | 1 | 2003 | 38 | 0.050 |
Why?
|
| Binding Sites | 1 | 2006 | 1133 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1133 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2003 | 74 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2003 | 66 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2003 | 108 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 110 | 0.050 |
Why?
|
| Immunity, Cellular | 2 | 2015 | 183 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 555 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2003 | 79 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 1338 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2003 | 163 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1261 | 0.040 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2001 | 4 | 0.040 |
Why?
|
| Avian Proteins | 1 | 2001 | 18 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 119 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2001 | 43 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2001 | 222 | 0.040 |
Why?
|
| Catalysis | 1 | 2001 | 216 | 0.040 |
Why?
|
| Gamma Rays | 2 | 2011 | 73 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 2015 | 134 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 209 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 404 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2021 | 64 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2021 | 124 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 1985 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 587 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2003 | 366 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 193 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2011 | 352 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1587 | 0.040 |
Why?
|
| Mitomycin | 2 | 2012 | 29 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2026 | 0.040 |
Why?
|
| Gene Library | 1 | 1999 | 126 | 0.040 |
Why?
|
| Mutagenesis | 1 | 1999 | 192 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 103 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 273 | 0.040 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 1998 | 1 | 0.040 |
Why?
|
| CHO Cells | 1 | 1998 | 187 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 164 | 0.030 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1998 | 97 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1998 | 384 | 0.030 |
Why?
|
| Cricetinae | 1 | 1998 | 532 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 618 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 1301 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1914 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2008 | 102 | 0.030 |
Why?
|
| Phylogeny | 1 | 2001 | 1266 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 2464 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 47 | 0.030 |
Why?
|
| Immunochemistry | 1 | 1994 | 18 | 0.030 |
Why?
|
| Spores, Fungal | 1 | 1994 | 18 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 110 | 0.030 |
Why?
|
| Genotype | 1 | 1999 | 1866 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1994 | 69 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 74 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 119 | 0.030 |
Why?
|
| Epitopes | 1 | 1994 | 254 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2015 | 138 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 1117 | 0.030 |
Why?
|
| Dimerization | 2 | 2004 | 148 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 399 | 0.020 |
Why?
|
| Fluorometry | 1 | 2013 | 30 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 304 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 376 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 379 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 361 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 100 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 824 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 2495 | 0.020 |
Why?
|
| OX40 Ligand | 1 | 2011 | 2 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2011 | 14 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 696 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2011 | 159 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 111 | 0.020 |
Why?
|
| Rotation | 1 | 2011 | 90 | 0.020 |
Why?
|
| Cysteine | 1 | 2012 | 145 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 2465 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 99 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 219 | 0.020 |
Why?
|
| Phthalazines | 1 | 2011 | 53 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2010 | 22 | 0.020 |
Why?
|
| Diploidy | 1 | 2010 | 34 | 0.020 |
Why?
|
| Haploidy | 1 | 2010 | 30 | 0.020 |
Why?
|
| Camptothecin | 1 | 2011 | 196 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 256 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2012 | 178 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 260 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 350 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 841 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 284 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 444 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2008 | 41 | 0.020 |
Why?
|
| Genome | 1 | 2011 | 407 | 0.020 |
Why?
|
| Glyoxal | 1 | 2007 | 1 | 0.020 |
Why?
|
| Acetaldehyde | 1 | 2007 | 7 | 0.020 |
Why?
|
| Acrolein | 1 | 2007 | 7 | 0.020 |
Why?
|
| Fanconi Anemia | 1 | 2007 | 9 | 0.020 |
Why?
|
| Pyruvaldehyde | 1 | 2007 | 10 | 0.020 |
Why?
|
| Aldehydes | 1 | 2007 | 21 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2007 | 110 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 153 | 0.020 |
Why?
|
| Glutathione | 1 | 2007 | 105 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 476 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2010 | 443 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 531 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 556 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2006 | 33 | 0.020 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2006 | 35 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2006 | 34 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 34 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2007 | 784 | 0.010 |
Why?
|
| Genes, rev | 1 | 2005 | 1 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2005 | 4 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 464 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 22 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2005 | 17 | 0.010 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2005 | 2 | 0.010 |
Why?
|
| Magnesium Chloride | 1 | 2005 | 6 | 0.010 |
Why?
|
| Hindlimb | 1 | 2006 | 94 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 2005 | 11 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2005 | 29 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2005 | 68 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2006 | 168 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2005 | 36 | 0.010 |
Why?
|
| Melphalan | 1 | 2005 | 98 | 0.010 |
Why?
|
| Microscopy, Atomic Force | 1 | 2005 | 53 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2008 | 756 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 337 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 422 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 2544 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2005 | 234 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 342 | 0.010 |
Why?
|
| Sendai virus | 1 | 2003 | 7 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 2003 | 12 | 0.010 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2003 | 20 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 25 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 83 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 111 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 381 | 0.010 |
Why?
|
| Immune Sera | 1 | 2003 | 48 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2003 | 209 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2003 | 23 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1492 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 278 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 474 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 212 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2006 | 351 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 2479 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 369 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 524 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2003 | 476 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2003 | 191 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 541 | 0.010 |
Why?
|
| Male | 1 | 2006 | 44557 | 0.000 |
Why?
|